Dimensions of Quality and Their Increasing Relevance for Visceral Medicine in Germany by Keßler, Wolfram & Heidecke, Claus-Dieter
Fax +49 761 4 52 07 14
Information@Karger.com
www.karger.com
Accessible online at: 
www.karger.com/vis
Review Article
Visc Med 2017;33:119–124
DOI: 10.1159/000462997
Dimensions of Quality and Their Increasing Relevance 
for Visceral Medicine in Germany
Wolfram Keßler a    Claus-Dieter Heidecke a, b
a
 Department of General, Visceral, Thoracic and Vascular Surgery, Universitätsmedizin Greifswald, Greifswald, Germany; 
b
 Chirurgische Arbeitsgemeinschaft für Qualität, Sicherheit und Versorgungsforschung (CAQS-V), Deutsche Gesellschaft für Chirurgie 
  (DGCH), Berlin, Germany
Introduction
The German lawgiver has set new rules in 2016 by implement-
ing the so-called ‘hospital structure law’ [1]: ‘the quality of inpa-
tient medical care in the future will be taking on a larger role ac-
companied by stricter controlling as well as consequential im-
provement. Quality will be introduced as a criterion in hospital 
planning and obligation to the quality assurance regulations devel-
oped by the Federal Joint Committee (G-BA) will be strengthened. 
The minimum quantity regulation will be applied in strict legal ac-
cordance to the law … Autonomy for medical decisions will be-
come increased … Hospital compensation will become closely tied 
to qualitative aspects and hospital quality reports will be designed 
in a more patient-friendly format so that useful information is 
more easily available.’ As can be seen from this, the legislator is se-
rious about enforcing quality measures.
Quality has always been an important aspect in surgery. Theo-
dor Billroth’s statement ‘Nothing is worse than the obscurity of 
one’s own actions’ already addressed this long ago. A critical view 
of one’s own work is essential. The quality offensive undertaken by 
the German Federal Government also focuses on the high value of 
quality. Proof of quality (a monodimensional term generally used 
by politics) is, however, clearly more problematic. The primary 
issue is that the term quality is extremely difficult to define.
The Problem with the Term ‘Quality’
On the homepage of the German Society for Quality (Deutsche 
Gesellschaft für Qualität e.V.) the following definition of quality 
can be found: ‘To do the right thing correctly’ [2]. Thus, it can al-
ready be assumed that quality is based upon whoever is judging it 
or, in other words, whoever rules what is correct or sets the re-
quirements to develop a precedent.
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Summary
Background: ‘Quality in medicine’ is a term used in a 
broad sense. In this work the definition and dimensions 
of quality in medicine and the implementation of a 
measurement and reporting system in Germany are dis-
cussed. Existing applications are described and possible 
future effects are pointed out. Methods: The ongoing 
process of implementing a quality reporting system into 
the German healthcare system is studied by publicly 
available legal texts, published reactions of stakeholders 
and publications of G-BA and IQTIG. Definitions of quality, 
dimensions of quality and quality measurement in medi-
cine are studied by using textbooks as well as the world 
wide web and PubMed search. Results: Donabedian‘s ‘di-
mensions of quality’ are fundamental in dealing with 
quality in medicine. Existing measurement and reporting 
systems have immanent strengths and weaknesses, as 
the definition of quality is affected by one‘s point of view. 
The legislator will have to decide which ‘dimension of 
quality’ is mandatory and how to measure it. Conclu-
sion: Quality has become a control instrument with un-
foreseeable consequences. A clear definition of the used 
quality concept is as essential as the use of feasible 
measurement and reporting systems. The use of routine 
data could be an interesting option. 
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Two differing quality concepts can be derived from classic busi-
ness management teachings. The first covers product-based quality 
terms which can be developed and measured according to tangible 
characteristics of products. The second involves customer-based 
quality terms, whereby the extent of quality reflects its usefulness 
or the value of a product observed by the consumer [3]. Ultimately, 
quality will be evaluated by the comparison between the usefulness 
and the price/sacrifice by the customer. Surgeons can certainly 
identify with this in terms of medical products for the operating 
room. In the same sense, it can be concluded that for a health sys-
tem, quality criteria compliance and its set cost would have to be 
defined beforehand.
A successful definition of quality in medicine was offered by the 
Institute of Medicine in 1990: Quality of care is the degree to which 
health services for individuals and populations increase the likeli-
hood of desired health outcomes and are consistent with current 
professional knowledge [4]. This definition describes the quality of 
health provision from the viewpoint of the patient and correlates it 
with the status of research or evidence-based medicine. Though 
more theoretical than actually realizable, this definition gave cause 
for discussion not only in the USA, pertaining to adjustments of 
health care policy to the health care system. In 2001, the ‘6 domains 
of health care quality’ were presented [5, 6]. The quality of the 
health care system should hereby fulfill the six aspects which are 
stated in table 1.
The distribution into six categories provides the possibility of 
working structurally within each dimension, whereby distinct goals 
for each aspect should be provided. In Germany, general regula-
tions and particularly legislation are based upon the classical di-
mensions of quality first published by Donabedian [7] in 1966. He 
divided quality within health care into three categories: structural, 
process and outcome quality. According to Donabedian, structural 
quality is based upon the right prerequisites in facility, equipment 
as well as human and technical resource. Process quality is simply 
doing the right thing correctly by delivering proper treatment. 
Outcome quality is the accomplishment of an intended condition 
[7]. Often a fourth element is introduced involving the so-called 
‘quality of experience’, where patient satisfaction, in the widest 
sense, is strongly focused upon in terms of participation and less in 
terms of wellness [8].
Though structure and process quality can be easily measured 
and therefore quickly optimized, there is no guarantee that the out-
come quality will simultaneously increase, too. Exclusive focus 
solely upon structure and process measures only makes sense when 
a positive correlation to outcome quality can be all but proven or 
substantiated [9].
How Is Quality Measured in Medicine?
The definition of quality is not simple, while its detailed meas-
urement is similarly complex. Quite often quality indicators (quan-
titative figures) are used in several areas of the health care system 
to evaluate presumably important functions. An indicator, how-
ever, is not a direct measurement of quality. It is more a tool which 
can be used in performance evaluation which directs attention to 
potential problem areas requiring intensive examination within an 
organization. The evaluation of quality via the use of indicators ini-
tially serves the improvement of quality [10]. Commonly, well-de-
fined structure, process or outcome indicators serve as quality indi-
cators in medicine. The question of which quality indicator will be 
drawn upon for which question is up to the institution which sets 
the standards or the agency which operates registries. Controver-
sies do naturally arise, as was recently the case concerning the first 
quality report of the Institute for Quality Assurance and Transpar-
ency in Healthcare (Institut für Qualitätssicherung und Transpa-
renz im Gesundheitswesen (IQTIG)). Similarly, the quality indica-
tors obtained from routine data employed by the health insurances, 
namely the AOK (local health care funds) together with the WIdO 
Institute (Wissenschaftliches Institut der AOK; research institute 
of the local health care funds), are the subject of extensive discus-
sion. Here, ICD (International Classification of Diseases) codes or 
OPS (Operation and Procedure codes) for certain illnesses are used 
as quality indicators. In terms of risk adjustment, it is important to 
include the patients’ severity of disease in the quality evaluation. It 
is also essential that the quality indicators include correct compli-
cation potential for an index patient which, unfortunately, the Ger-
man ICD-10 system does not always satisfactorily provide (e.g. 
classification of liver cirrhosis, intake of corticosteroids or 
immunosuppressives).
Prospects for Quality Rating by Internal Quality  
Assurance
In the past, quality was documented for self-interest reasons in 
more or less sophisticated databases for the purpose of internal 
quality assurance. Instruments such as the Clavien-Dindo Classifi-
Table 1. Factors for assessing the quality of the health care system
Safe Avoiding harm to patients from the care that is intended  
to help them.
Effective Providing services based on scientific knowledge to all  
who could benefit and refraining from providing services to 
those not likely to benefit (avoiding underuse and misuse).
Patient-centered Providing care that is respectful of and responsive to  
individual patient preferences, needs, and values and  
ensuring that patient values guide all clinical decisions.
Timely Reducing waiting time and sometimes harmful delays for 
both those who receive and those who give care.
Efficient Avoiding waste, including waste of equipment, supplies, 
ideas, and energy.
Equitable Providing care that does not vary in quality because  
of personal characteristics such as gender, ethnicity,  
geographic location, and socioeconomic status.
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cation [11] were often employed to evaluate quality outcome in pa-
tients with abnormal courses of a disease.
Quality assurance within a ‘protected area’ has been provided 
by medical societies or the An-Institute for Quality Assurance in 
Operative Medicine in Magdeburg, thereby allowing benchmark-
ing with other hospitals. In the past few years, medical societies 
such as the German Society for General and Visceral Surgery 
(DGAV) and the German Society of Orthopedic and Trauma Sur-
gery (DGOU) have gained recognition for the development of such 
registries. It can be criticized, however, that the definition of the 
parameters for quality indicators are chosen arbitrarily by the reg-
istry which could make the fulfillment of requirements easy or dif-
ficult. The administrators of the registry determine the ‘rules of the 
game’ for which and to which extent parameters are to be docu-
mented. Critics claim that overwhelming requirements of clinical 
parameters would lead to incomplete data reporting, thereby low-
ering the quality. Well-organized registry data are, however, a suit-
able option for quality assurance in terms of providing realistic an-
swers to certain care provider questions [12, 13].
A further form of internal quality assurance with the option of 
benchmark creation is possible by means of certification by e.g. the 
DGAV or the German Cancer Society (DKG). Within the certifica-
tion framework of the DGAV, participation in the registry system 
(StuDoQ) is mandatory. Outcome and process quality are closely 
monitored at the time of certification as well as at re-certification 
[14]. All centers must fulfill the minimum quantity regulations. 
Since 2013, quality assurances for the DKG and the German Can-
cer Aid (DKH) have been harmonized [15]. Both organizations 
distribute questionnaire forms. The goal is that the same rules 
apply for oncological treatment in all certified centers, thus result-
ing in comparable treatment results. In order to form quality indi-
cators from guidelines, a methodology paper was developed using 
the framework of the oncological guideline programs from the 
DKG, the DKH, and the Association of the Scientific Medical Soci-
eties in Germany (AWMF) [16]. Revision of the oncological qual-
ity indicators is undertaken yearly. All dimensions of quality for 
the certified oncological sector are questioned, starting with the 
qualification of the provider (structure quality), the availability of 
distinct treatment process elements (process quality), patient fol-
low-up controls (outcome quality), and, finally, critical self-assess-
ment with problem cases (morbidity-mortality conferences). Pa-
tient satisfaction is also taken into consideration by means of pa-
tient questionnaires.
Feasibility of Quality Assessment by External  
Quality Assurance
External quality assurance is long well established in Germany. 
In 2016, this function was transferred to the newly founded IQTIG 
as cross-sectoral quality assurance. According to the data of the ex-
ternal Quality and Safety (QS) from 2008 until 2011, the quality of 
inpatient care had either improved (36%) or remained stable 
(59%). Only 5% of the quality indicators had worsened [17].
The quality offensive in medicine undertaken by the Federal 
Government was effectively implemented via the so-called Hospi-
tal Structures Act and an announcement in the Federal Law Ga-
zette. According to §135 SGB V (social code book V), quality as-
surance in medicine is to be understood as widely comprehensive 
and is separated from quality management in the facility. Partici-
pation in both processes (cross-sectoral quality assurance as well as 
internal quality management of the facility) is compulsory and en-
compasses primarily outcome quality. All players in health care 
(contractual doctors, medical care centers, accredited hospitals, 
providers of preventive treatment or rehabilitation measures as 
well as facilities with patient care provision contracts according to 
§111a) have to participate. In addition, according to §136 SGB V, 
minimal requirements regarding structure, process and outcome 
quality should be defined by the Federal Joint Committee (Ge-
meinsamer Bundesausschuss (G-BA)) in certain areas of medical 
care.
According to §137 SGB V, within the framework of external 
comparative quality assurance for inpatient care, hospitals are 
obliged to report quality-relevant data for defined medical treat-
ment areas to the IQTIG. Founded in 2015, the IQTIG presently 
includes 110 staff members and bears the entire responsibility for 
the legally determined quality assurance according to paragraphs 
136ff und 137a SGB V since January 2016. An initial report has al-
ready been presented including 1,834 participating hospitals, 3.2 
million quality assurance data records, 25 areas of treatment (QS 
procedure), 351 quality indicators, and 91 risk adjustment indica-
tors [18]. As already mentioned, the quality indicators remain the 
subject of discussion, and appropriate further development re-
mains the core task of the institute. An initial guideline for future 
hospital development planning according to relevant quality indi-
cators in gynecology has been developed and was released on De-
cember 15th, 2016 [19].
Data delivered to the IQTIG are statistically evaluated according 
to nationwide, uniform concepts according to which risk adjust-
ment takes place. The results are made available to the participat-
ing hospitals and are also made public in a comprehensible form 
[18]. Detection of site-related abnormalities is handled by struc-
tured dialogue pertaining to the regulations. In the instance of vio-
lations against quality requirements, the following measures of 
sanction according to §137 SGB V are possible:
– reductions in reimbursement,
–  loss of reimbursement rights for services where the minimal 
standards according §136 SGB V are not met,
– report of violation of a third party,
–  institution-related disclosure of information pertaining to non-
adherence to quality requirements.
Furthermore, when authorized by the G-BA or defined posts, 
the Medical Service of the Statutory Health Insurance Funds 
(Medizinischer Dienst der Krankenkassen (MDK)) is permitted to 
make unannounced control checks of quality requirements, docu-
mentation of external quality assurance, and adherence to state 
quality regulations [20]. In addition, quality contracts with the 
health care insurances should also be deemed permissible [21].
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Currently, the following medical areas from the operative spe-
cialties are presented:
– obstetrics,
– gynecological procedures (excluding hysterectomy),
– breast surgery,
– heart pacemaker provision including defibrillators,
– hip and knee endoprosthesis provision,
– carotid revascularisation,
– aortic valve and combined coronary and aortic valve surgery,
– transplantation surgery.
This list will naturally be expanded in the future.
The development of expanded monitoring as well as the option 
to sanction health care providers are also new since the founding of 
the IQTIG; these measures can and will very likely be employed in 
the planning of the hospital landscape.
Feasibility of Quality Assurance Using Routine Data
In 2002, quality assurance through routine data (Qualitätssi-
cherung mit Routinedaten (QSR)) was initiated as a cooperative 
development project by the WIdO, the AOK Federal Association, 
the Helios Clinics Group, and the Research and Development In-
stitute for Social and Public Health Saxony-Anhalt (Forschungs- 
und Entwicklungsinstitut für das Sozial- und Gesundheitswesen 
Sachsen-Anhalt). The project has been continuously developed 
further by the WldO since 2008. The goal was to develop and es-
tablish a low-effort, non-complex quality measurement method for 
Germany, using so-called routine data which would be focused on 
outcome quality. At present, 18 treatment areas are covered by 
QSR indicators, two of which are visceral surgery-related: appen-
dectomy and cholecystectomy. The treatment areas including be-
nign thyroid disease have not been publicly reported. Treatment 
areas comprising gastroenterology or endoscopy do not exist yet.
QSR is based upon AOK billing data in an anonymous form 
(synonymous: routine data, administrative data, secondary data) 
which, according to §301 SGB V, are reported to the health insur-
ance by the hospitals. This data include information pertaining to 
the length of hospital stay, diagnoses, procedures, and amount of 
case-related revenues of the hospital for inpatient treatment. These 
data are combined with data (also made anonymous) regarding age 
and sex of the patient as well as insurance and survival status. Fol-
low-up G-BA practice visits and readmissions are added to the 
data. Through the use of the QSR procedure it is ultimately possi-
ble to allocate various hospital stays and practice visits to one pa-
tient without repeated identification of the person [22].
The central advantage of QSR over traditional quality assurance 
processes is that occurrences such as ambulatory visits (not at the 
treating hospital) flow into the database and are included. In Ger-
many, where the ambulatory and the inpatient sector are strictly 
separated, the QSR process offers a solution by providing an inter-
face which, by means of cross-sectoral quality assurance, at best 
proves to be a challenge. Thus, a routine, long-term follow-up is 
possible for the first time. At the same time, additional documenta-
tion can be avoided due to already available administrative and bill-
ing data being accessible. It can be readily assumed that the re-
source-relevant data submitted by the hospitals are complete be-
cause the hospital is steering its revenue by means of these data [22].
With the use of QSR, the quality measurement of hospitals is 
primarily directed toward analysis and evaluation of outcome indi-
cators such as hospital mortality as well as 30-day, 90-day and 
1-year mortality rate. In addition, general as well as treatment-spe-
cific complications or adverse events during the hospital stay as 
well as complication-related readmission or undesired subsequent 
events occurring up to 1 year after the initial treatment are in-
cluded [22]. A list of quality indicators for each medical area can be 
found in the indicator handbook [23].
The expected events are measured with the help of a logistic re-
gression model. In order to guarantee a fair comparison between 
the hospitals, a risk adjustment according to patient characteristics 
is carried out. This risk adjustment is performed based upon sex, 
age, and approximately 30 relevant concomitant illnesses of the pa-
tients as well as other factors which are treatment-dependent, such 
as the employed procedures. Only concomitant illnesses which pre-
sumably existed prior to inpatient admission are used for risk ad-
justment. Risk adjustment is reviewed once a year and audited for 
systematic discrepancies. The QSR project is attended to by a scien-
tific advisory board as well as by expert panels from the treatment 
areas (e.g. expert panel visceral surgery or endocrine surgery) [24].
Critics of QSR question whether risk adjustment can be cor-
rectly performed for individual high-risk patients or for hospitals 
with a high frequency of admitted high-risk patients (e.g. for the 
distribution of so-called ‘life trees’). The problem therein is that 
sometimes the pre-existing morbidity of the patient cannot be 
clearly separated from newly acquired diagnoses due to the limited 
differentiation of the German ICD-10 system. As already men-
tioned, the rendering of specific patient conditions with the Ger-
man ICD-10 system is insufficient. Therefore, a revision of the 
ICD-10 system would be necessary to make patient-related risk 
stratification more objective. There should also be better options to 
code the severity of manifestation of the main diagnosis. It is unde-
niable that in view of the complication potential, there is a consid-
erable risk difference between a symptomatic cholecystolithiasis 
within a structurally intact gall bladder and a gangrenous cholecys-
titis in the presence of numerous inflammatory symptoms. If all 
cases of cholecystitis were exactly the same, then the point of time 
for surgical treatment would not have shown any difference for the 
patients’ morbidity in the ACDC trial [25]. An ICD and OPS sys-
tem which takes the need for quality assurance and risk stratifica-
tion into consideration would clearly solve many problems.
What Is Important for the Quality of Visceral  
Medicine in the Future?
The current debate on quality encompasses all areas of medi-
cine. Even if the vast majority of quality indicators is predomi-
nantly employed for operative procedures, it is only a question of 
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time before the instruments for external quality assurance as well 
as those from the QSR will be applied for usage in the interven-
tional and conservative treatment areas. It remains to be seen what 
the impact of the implementation of the Hospital Structures Act 
will be. In the presence of quality awards, surcharges, and strict 
minimum quantity regulations, there will definitely be ‘winners 
and losers’ within the system. The total number of monitored pro-
cedures/illnesses is still limited. Further extension of the QSR sys-
tem in the future will not only have an impact on visceral surgery 
but also on gastroenterology and endoscopy. It can be expected 
that the reporting time intervals for QS data sent to the IQTIG will 
be distinctly shortened and that reporting will occur several times 
during the year [19].
It would be wise if the field of visceral medicine became in-
volved in the debate on quality indicators as these data will eventu-
ally steer the health care system in the direction of ‘pay for perfor-
mance’ (P4P). P4P basically means that health care providers 
should be motivated by differentiated financial incentives to de-
liver quality and efficiency in their code of practice in a sustainable, 
optimal and further developing manner. Until now, P4P has not 
demonstrated any significant benefits within the hospital sector 
[26]. Nevertheless, well-planned and orchestrated P4P studies 
should be performed before politics decides on new programs 
based upon unsatisfactory data [27]. Most importantly, new P4P 
instruments need to be found since those pre-existing indicators, 
which were not designed for P4P, should not be applied due to 
their unsuitability.
In the near future, escalated due to the minimal requirement 
regulation in the field of esophageal and pancreatic surgery, a 
stronger focus will be placed upon specialization. If this minimal 
requirement regulation is furthered by the legislator to other areas 
of surgery, a similar effect can be expected. Specialization and for-
mation of specialized centers present an important prognosis fac-
tor for patients. Reports from countries where the centralization of 
complex surgical procedures has already taken place substantiate 
this fact [28]. A recent study commissioned by the Bertelsmann 
Foundation and presented by the Institute for Health and Social 
Research (Institut für Gesundheits- und Sozialforschung (IGES)) 
in Berlin confirmed these international findings. By means of such 
analyses, reliable knowledge can be gathered and used in the politi-
cal discussion about health and the distribution of care [29]. The 
advantage of selected operations being frequently carried out at 
designated centers then appears economically sensible [30].
When it comes to quality assurance, several surgical societies 
have laid an excellent groundwork. The field of visceral surgery has 
done so due to the efforts of the DGAV. Numerous registries have 
been made available with the option of quality assurance as well as 
the opportunity to benchmark for participating centers. Some indi-
vidual data sheets, however, are subjectively quite extensive which 
places a high demand on those colleagues responsible for the data 
input. Consequently, the completeness and validity of the entered 
data is determined by the institution itself. If the intention of the 
registry is a focus on health service research, outcome quality from 
registries may show results incongruent with the institution’s qual-
ity expectations if the quality indicators were chosen as such.
Presently it is unclear in which direction the G-BA or the 
IQTIG wish to further develop the external quality assurance, i.e. 
related to procedures/operations or to diseases. It is also undecided 
how the IQTIG will value certificates and certification processes. 
Both decisions would set a trend as they would strengthen local or 
regional center development for oncological or complex visceral 
diseases such as obesity or inflammatory bowel disease. Together 
with a stricter minimum quantity regulation this would clearly 
change the hospital landscape. Furthermore, this would have an 
extensive impact upon the structure of departments as well as hos-
pitals and thereby also upon residency programs.
The legislation during this period has developed instruments 
which could alter the health care system in a non-foreseeable man-
ner. In addition to the current system, quality assurance using rou-
tine data will play a greater role as the health insurances actively 
promote it. The options of implementing ‘quality contracts’ [21] 
could provide allocative functions. The structural as well as pro-
cess-related quality stipulations of the G-BA will regulate which 
institutions will be allowed to participate in providing health care. 
In addition, the emphasis on outcome quality should finally im-
prove the delivery of medical care. It remains to be seen whether a 
concentration of the hospital landscape due to economic pressure 
will occur prior to the effects of these quality measures. In this case, 
not the ‘best’ hospitals will survive but the most efficient ones.
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